image
Healthcare - Biotechnology - NASDAQ - US
$ 45.9009
0.0897 %
$ 2.27 B
Market Cap
-27.73
P/E
Price Target Average
22.73%
Revenue Forecast Estimate
28.52%
EBIT Estimate
--43.23%
Net Income Estimate
36.96%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Mirum Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for MIRM of $56.3 , with forecasts ranging from a low of $39 to a high of $70 .
MIRM Lowest Price Target Wall Street Target
39 USD -15.03%
MIRM Average Price Target Wall Street Target
56.3 USD 22.73%
MIRM Highest Price Target Wall Street Target
70 USD 52.50%
Price
Max Price Target
Min Price Target
Average Price Target
707065656060555550504545404035353030Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart MIRM

image
$1.0b$1.0b$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MIRM

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MIRM

image
$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029